KALA BIO, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was USD 10.41 million compared to USD 28.11 million a year ago. Basic loss per share from continuing operations was USD 4.36 compared to USD 18.92 a year ago. Diluted loss per share from continuing operations was USD 4.36 compared to USD 18.92 a year ago.
For the six months, net loss was USD 24.87 million compared to USD 61.05 million a year ago. Basic loss per share from continuing operations was USD 11.15 compared to USD 41.1 a year ago. Diluted loss per share from continuing operations was USD 11.15 compared to USD 41.1 a year ago.